173 related articles for article (PubMed ID: 8337847)
21. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
[TBL] [Abstract][Full Text] [Related]
22. Interactions between Tat of HIV-2 and transcription factor Sp1.
Pagtakhan AS; Tong-Starksen SE
Virology; 1997 Nov; 238(2):221-30. PubMed ID: 9400595
[TBL] [Abstract][Full Text] [Related]
23. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
[TBL] [Abstract][Full Text] [Related]
24. Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes.
Chipitsyna G; Sawaya BE; Khalili K; Amini S
J Cell Physiol; 2006 Jun; 207(3):605-13. PubMed ID: 16511829
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
Jiang MC; Lin JK; Chen SS
Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
[TBL] [Abstract][Full Text] [Related]
26. Molecular approaches to inhibit HIV-1 tat expression and functions.
Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
[No Abstract] [Full Text] [Related]
27. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat).
Derse D; Dorn P; DaSilva L; Martarano L
Dev Biol Stand; 1990; 72():39-48. PubMed ID: 2178129
[TBL] [Abstract][Full Text] [Related]
28. Tat-induced lesions in transgenic mice do not correlate with the HIV-1 LTR transactivation.
Fergelot P; Molina T; Blanchet P; Grimber G; Duquenne O; Couton D; Zider A; Briand P; Cavard C
C R Acad Sci III; 1995 Mar; 318(3):329-37. PubMed ID: 7788501
[TBL] [Abstract][Full Text] [Related]
29. Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1.
Reddy MV; Desai M; Jeyapaul J; Prasad DD; Seshamma T; Palmeri D; Khan SA
Oncogene; 1992 Sep; 7(9):1743-8. PubMed ID: 1501886
[TBL] [Abstract][Full Text] [Related]
30. Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure.
Berkhout B; Gatignol A; Silver J; Jeang KT
Nucleic Acids Res; 1990 Apr; 18(7):1839-46. PubMed ID: 2186367
[TBL] [Abstract][Full Text] [Related]
31. Codelivery to mammalian cells of a transcriptional factor with cis-acting element using cationic liposomes.
Farhood H; Gao X; Barsoum J; Huang L
Anal Biochem; 1995 Feb; 225(1):89-93. PubMed ID: 7778790
[TBL] [Abstract][Full Text] [Related]
32. Epithelin/granulin growth factors: extracellular cofactors for HIV-1 and HIV-2 Tat proteins.
Trinh DP; Brown KM; Jeang KT
Biochem Biophys Res Commun; 1999 Mar; 256(2):299-306. PubMed ID: 10079180
[TBL] [Abstract][Full Text] [Related]
33. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
Gatignol A; Duarte M; Daviet L; Chang YN; Jeang KT
Gene Expr; 1996; 5(4-5):217-28. PubMed ID: 8723388
[TBL] [Abstract][Full Text] [Related]
34. Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.
Elangovan B; Subramanian T; Chinnadurai G
J Virol; 1992 Apr; 66(4):2031-6. PubMed ID: 1548750
[TBL] [Abstract][Full Text] [Related]
35. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
Rhim H; Rice AP
Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
[TBL] [Abstract][Full Text] [Related]
36. The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression.
Kim YS; Panganiban AT
J Virol; 1993 Jul; 67(7):3739-47. PubMed ID: 8510203
[TBL] [Abstract][Full Text] [Related]
37. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells.
Alonso A; Derse D; Peterlin BM
J Virol; 1992 Jul; 66(7):4617-21. PubMed ID: 1602563
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.
Kolson DL; Collman R; Hrin R; Balliet JW; Laughlin M; McGann KA; Debouck C; Gonzalez-Scarano F
J Gen Virol; 1994 Aug; 75 ( Pt 8)():1927-34. PubMed ID: 8046394
[TBL] [Abstract][Full Text] [Related]
39. On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation.
Verhoef K; Bauer M; Meyerhans A; Berkhout B
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1553-9. PubMed ID: 9840288
[TBL] [Abstract][Full Text] [Related]
40. The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.
Delling U; Roy S; Sumner-Smith M; Barnett R; Reid L; Rosen CA; Sonenberg N
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6234-8. PubMed ID: 2068104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
